MINI FUTURE OPTIONSSCHEIN - BOSTON SCIENTIFIC | Real-time Bid/Ask 05:52:19 2024-06-07 EDT | ||
| 1.59 EUR / 1.66 EUR | +0.93% |
|
| Current month | -5.29% | ||
| 1 month | -17.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 1.61 | 0.00% |
| 24-06-06 | 1.61 | -1.83% |
| 24-06-05 | 1.64 | +1.23% |
| 24-06-04 | 1.62 | -2.99% |
| 24-06-03 | 1.67 | -1.76% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 03:18 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JB7PM2 |
| ISIN | DE000JB7PM20 |
| Date issued | 2023-12-05 |
| Strike | 93.48 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.63 € |
|---|---|
| Lowest since issue | 1.57 € |
| Spread | 0.07 € |
| Spread % | 4.14% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.12
USD
Average target price
82.06
USD
Spread / Average Target
+7.81%
- Stock Market
- Certificates
- Certificat
